BCR and lymphoma: By combining JCM features from multiplexed panels of 16 phospho-markers, we identified a novel spatio-temporal signature of BCR signaling in a specific subpopulation of the lymphoma B cells that improved the separation between two classes of patients previously reported by Irish et al. [9] to have markedly different survival.